CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2021	$ 459,638	$ 5	$ 689,275	$ (228,982)	$ (660)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021		51,536,181
Exercise of stock options	826		826
Exercise of stock options, Shares		262,527
Vesting restricted stock, Shares		27,248
Issuance of shares under employee stock purchase plan	256		256
Issuance of shares under employee stock purchase plan, Shares		21,093
Stock-based compensation expense	17,495		17,495
Unrealized gain (loss) on marketable securities	(3,323)				(3,323)
Net loss	(76,941)			(76,941)
Ending Balance at Jun. 30, 2022	397,951	$ 5	707,852	(305,923)	(3,983)
Shares, Outstanding, Ending Balance at Jun. 30, 2022		51,847,049
Beginning Balance at Mar. 31, 2022	428,720	$ 5	697,597	(265,666)	(3,216)
Shares, Outstanding, Beginning Balance at Mar. 31, 2022		51,692,666
Exercise of stock options	377		377
Exercise of stock options, Shares		120,257
Vesting restricted stock, Shares		13,033
Issuance of shares under employee stock purchase plan	256		256
Issuance of shares under employee stock purchase plan, Shares		21,093
Stock-based compensation expense	9,622		9,622
Unrealized gain (loss) on marketable securities	(767)				(767)
Net loss	(40,257)			(40,257)
Ending Balance at Jun. 30, 2022	397,951	$ 5	707,852	(305,923)	(3,983)
Shares, Outstanding, Ending Balance at Jun. 30, 2022		51,847,049
Beginning Balance at Dec. 31, 2022	490,151	$ 6	878,884	(383,790)	(4,949)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022		55,039,380
Exercise of stock options	2,163		2,163
Exercise of stock options, Shares		276,692
Vesting restricted stock, Shares		34,764
Issuance of shares under employee stock purchase plan	962		962
Issuance of shares under employee stock purchase plan, Shares		39,423
Stock-based compensation expense	20,565		20,565
Unrealized gain (loss) on marketable securities	1,314				1,314
Net loss	(79,727)			(79,727)
Ending Balance at Jun. 30, 2023	435,428	$ 6	902,574	(463,517)	(3,635)
Shares, Outstanding, Ending Balance at Jun. 30, 2023		55,390,259
Beginning Balance at Mar. 31, 2023	462,005	$ 6	889,755	(424,718)	(3,038)
Shares, Outstanding, Beginning Balance at Mar. 31, 2023		55,276,226
Exercise of stock options	676		676
Exercise of stock options, Shares		67,987
Vesting restricted stock, Shares		6,623
Issuance of shares under employee stock purchase plan	962		962
Issuance of shares under employee stock purchase plan, Shares		39,423
Stock-based compensation expense	11,181		11,181
Unrealized gain (loss) on marketable securities	(597)				(597)
Net loss	(38,799)			(38,799)
Ending Balance at Jun. 30, 2023	$ 435,428	$ 6	$ 902,574	$ (463,517)	$ (3,635)
Shares, Outstanding, Ending Balance at Jun. 30, 2023		55,390,259